GNLX
Price
$3.11
Change
+$0.21 (+7.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
109.05M
14 days until earnings call
SPRB
Price
$0.14
Change
+$0.01 (+7.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
5.6M
13 days until earnings call
Ad is loading...

GNLX vs SPRB

Header iconGNLX vs SPRB Comparison
Open Charts GNLX vs SPRBBanner chart's image
Genelux
Price$3.11
Change+$0.21 (+7.24%)
Volume$3.76K
Capitalization109.05M
Spruce Biosciences
Price$0.14
Change+$0.01 (+7.69%)
Volume$75.11K
Capitalization5.6M
GNLX vs SPRB Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. SPRB commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a StrongBuy and SPRB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GNLX: $2.90 vs. SPRB: $0.13)
Brand notoriety: GNLX and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 98% vs. SPRB: 87%
Market capitalization -- GNLX: $109.05M vs. SPRB: $5.6M
GNLX [@Biotechnology] is valued at $109.05M. SPRB’s [@Biotechnology] market capitalization is $5.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRB is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 4 TA indicator(s) are bullish while SPRB’s TA Score has 4 bullish TA indicator(s).

  • GNLX’s TA Score: 4 bullish, 5 bearish.
  • SPRB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SPRB is a better buy in the short-term than GNLX.

Price Growth

GNLX (@Biotechnology) experienced а +12.84% price change this week, while SPRB (@Biotechnology) price change was +7.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

GNLX is expected to report earnings on May 08, 2025.

SPRB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($109M) has a higher market cap than SPRB($5.6M). GNLX YTD gains are higher at: 22.881 vs. SPRB (-68.405). GNLX has higher annual earnings (EBITDA): -26.78M vs. SPRB (-39.02M). SPRB has more cash in the bank: 60.1M vs. GNLX (34.1M). GNLX has less debt than SPRB: GNLX (2.04M) vs SPRB (3.23M). SPRB has higher revenues than GNLX: SPRB (7.1M) vs GNLX (8K).
GNLXSPRBGNLX / SPRB
Capitalization109M5.6M1,946%
EBITDA-26.78M-39.02M69%
Gain YTD22.881-68.405-33%
P/E RatioN/AN/A-
Revenue8K7.1M0%
Total Cash34.1M60.1M57%
Total Debt2.04M3.23M63%
TECHNICAL ANALYSIS
Technical Analysis
GNLXSPRB
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USGDF0.13N/A
+0.88%
American Pacific Mining Corp.
HESAY267.652.18
+0.82%
Hermes International SA
HENOY19.430.12
+0.61%
Henkel AG & Co. KGAA
BZLFY15.85-0.02
-0.13%
Bunzl plc
AUOTY5.19-0.03
-0.57%
AUO CORPORATION

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-1.36%
VSTM - GNLX
47%
Loosely correlated
+1.14%
SNSE - GNLX
33%
Poorly correlated
+6.90%
HOOK - GNLX
31%
Poorly correlated
+4.00%
ANIX - GNLX
30%
Poorly correlated
+0.37%
SPRB - GNLX
27%
Poorly correlated
+2.39%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MTVA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+2.39%
MTVA - SPRB
66%
Loosely correlated
+6.68%
IMRX - SPRB
52%
Loosely correlated
+3.62%
MLEC - SPRB
51%
Loosely correlated
-9.65%
SCPX - SPRB
43%
Loosely correlated
+8.78%
GNFT - SPRB
39%
Loosely correlated
+11.03%
More